Modification of mesenchymal stem cells for cardiac regeneration

Bibliography

• Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007;59:418-58
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM. The risk of congestive heart failure: sobering lessons from the Framingham Heart Study. Curr Cardiol Rep 2001;3:184-90
   PubMedGoogle Scholar
• Fonarow GC. Heart failure: recent advances in prevention and treatment. Rev Cardiovasc Med 2000;1:25-33, 54
   PubMedGoogle Scholar
• Penn MS, Mangi AA. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res 2008;102:1471-82
   PubMed Web of Science ®Google Scholar
• Melo LG, Pachori AS, Kong D, Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation 2004;109:2386-93
   PubMed Web of Science ®Google Scholar
• Chiu RC, Zibaitis A, Kao RL, Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995;60:12-8
   PubMed Web of Science ®Google Scholar
• Li RK, Jia ZQ, Weisel RD, Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996;62:654-60
   PubMed Web of Science ®Google Scholar
• Scorsin M, Hagege AA, Dolizy I, Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation 1998;98:II151-5
   Google Scholar
• Kehat I, Kenyagin-Karsenti D, Snir M, Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-14
   PubMed Web of Science ®Google Scholar
• Makino S, Fukuda K, Miyoshi S, Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705
   PubMed Web of Science ®Google Scholar
• Toma C, Pittenger MF, Cahill KS, Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8
   PubMed Web of Science ®Google Scholar
• Taylor DA, Atkins BZ, Hungspreugs P, Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-33
   PubMed Web of Science ®Google Scholar
• Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004;116:639-48
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL, Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9
   PubMed Web of Science ®Google Scholar
• Blanpain C, Horsley V, Fuchs E. Epithelial stem cells: turning over new leaves. Cell 2007;128:445-58
   PubMed Web of Science ®Google Scholar
• Kumar S, Chanda D, Ponnazhagan S. Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 2008;15:711-5
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S, Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5
   PubMed Web of Science ®Google Scholar
• Chen SL, Fang WW, Ye F, Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-5
   PubMed Web of Science ®Google Scholar
• Katritsis DG, Sotiropoulou PA, Karvouni E, Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 2005;65:321-9
   PubMed Web of Science ®Google Scholar
• Schuleri KH, Boyle AJ, Hare JM. Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol 2007;180:195-218
   PubMedGoogle Scholar
• Heil M, Ziegelhoeffer T, Mees B, A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res 2004;94:573-4
   PubMed Web of Science ®Google Scholar
• Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004;364:183-92
   PubMed Web of Science ®Google Scholar
• Zhang M, Methot D, Poppa V, Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J Mol Cell Cardiol 2001;33:907-21
   PubMed Web of Science ®Google Scholar
• Psaltis PJ, Zannettino AC, Worthley SG, Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 2008;26:2201-10
   PubMed Web of Science ®Google Scholar
• Vertesaljai M, Piroth Z, Fontos G, Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy. Heart Fail Rev 2008;13:227-44
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Briasoulis A, Antoniades C, Heart regeneration: what cells to use and how? Curr Opin Pharmacol 2008;8:211-8
   PubMed Web of Science ®Google Scholar
• Rezai N, Walinski H, Kerjner A, Methods for examining stem cells in post-ischemic and transplanted hearts. Methods Mol Med 2005;112:223-38
   PubMedGoogle Scholar
• Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845-56
   PubMed Web of Science ®Google Scholar
• Gulati R, Simari RD. Cell therapy for acute myocardial infarction. Med Clin North Am 2007;91:769-85; xiii
   PubMed Web of Science ®Google Scholar
• Min JY, Yang Y, Sullivan MF, Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003;125:361-9
   PubMed Web of Science ®Google Scholar
• Swijnenburg RJ, Tanaka M, Vogel H, Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005;112:I166-72
   PubMed Web of Science ®Google Scholar
• Choi JH, Choi J, Lee WS, Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction. Circ J 2007;71:486-94
   PubMed Web of Science ®Google Scholar
• Popogeff IA, Murray MR. The form and behaviour of adult mammalian skeletal muscle in vitro. Anat Rec 1946;95:321-36
   PubMedGoogle Scholar
• Pagani FD, DerSimonian H, Zawadzka A, Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-88
   PubMed Web of Science ®Google Scholar
• Menasché P, Alfieri O, Janssens S, The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008;117:1189-200
   PubMed Web of Science ®Google Scholar
• Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004;287:C572-9
   PubMed Web of Science ®Google Scholar
• Schmidt-Lucke C, Rössig L, Fichtlscherer S, Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-7
   PubMed Web of Science ®Google Scholar
• Smith RR, Barile L, Cho HC, Regenerative potential of cardiospherederived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007;115:896-908
   PubMed Web of Science ®Google Scholar
• Seandel M, James D, Shmelkov SV, Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature 2007;449:346-50
   PubMed Web of Science ®Google Scholar
• Guan K, Nayernia K, Maier LS, Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006;440:1199-203
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ. Osteogenetic activity of transplanted transitional epithelium. Acta Anat (Basel) 1961;45:31-59
   PubMedGoogle Scholar
• Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-6
   PubMed Web of Science ®Google Scholar
• Graf T. Differentiation plasticity of hematopoietic cells. Blood 2002;99:3089-101
   PubMed Web of Science ®Google Scholar
• Bartholomew A, Sturgeon C, Siatskas M, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-8
   PubMed Web of Science ®Google Scholar
• Devine SM, Bartholomew AM, Mahmud N, Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001;29:244-55
   PubMed Web of Science ®Google Scholar
• Devine SM, Cobbs C, Jennings M, Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003;101:2999-3001
   PubMed Web of Science ®Google Scholar
• Ghosh-Choudhury N, Abboud SL, Mahimainathan L, Phosphatidylinositol 3- kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene in cardiomyocyte precursor cells. J Biol Chem 2003;278:21998-2005
   PubMed Web of Science ®Google Scholar
• Freyman T, Polin G, Osman H, A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006;27:1114-22
   PubMed Web of Science ®Google Scholar
• Suzuki K, Murtuza B, Beauchamp JR, Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004;18:1153-5
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Yasuda T, Weisel RD, Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function. Am J Physiol Heart Circ Physiol 2006;291:H939-47
   Google Scholar
• Sadek HA, Martin CM, Latif SS, Bone-marrow-derived side population cells for myocardial regeneration. J Cardiovasc Trans Res 2009;2:173-81
   PubMed Web of Science ®Google Scholar
• Michel JB. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol 2003;23:2146-54
   PubMed Web of Science ®Google Scholar
• Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 2002;91:877-87
   PubMed Web of Science ®Google Scholar
• Chiarugi P, Giannoni E. Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 2008;76(11):1352-64
   PubMed Web of Science ®Google Scholar
• Mylotte LA, Duffy AM, Murphy M, Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells 2008;26:1325-36
   PubMed Web of Science ®Google Scholar
• Guo J, Lin GS, Bao CY, Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation 2007;30:97-104
   PubMed Web of Science ®Google Scholar
• Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-26
   PubMed Web of Science ®Google Scholar
• Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA 1980;77:4756-9
   PubMed Web of Science ®Google Scholar
• Chiarugi P, Giannoni E. Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 2008;76:1352-64
   PubMed Web of Science ®Google Scholar
• Song H, Chang W, Lim S, Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells. Stem Cells 2007;25:1431-8
   PubMed Web of Science ®Google Scholar
• Memon IA, Sawa Y, Fukushima N, Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 2005;130:1333-41
   PubMed Web of Science ®Google Scholar
• Sáenz-Morales D, Conde E, Escribese MM, ERK1/2 mediates cytoskeleton and focal adhesion impairment in proximal epithelial cells after renal ischemia. Cell Physiol Biochem 2009;23:285-94
   PubMed Web of Science ®Google Scholar
• Zhu WG, Li S, Lin LQ, Vascular oxidative stress increases dendritic cell adhesion and transmigration induced by homocysteine. Cell Immunol 2009;254:110-6
   PubMed Web of Science ®Google Scholar
• Yao EH, Yu Y, Fukuda N. Oxidative stress on progenitor and stem cells in cardiovascular diseases. Curr Pharm Biotechnol 2006;7:101-8
   PubMed Web of Science ®Google Scholar
• Pelegrin P, Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J 2009;28:2114-27
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem 2006;13(16):1877-93
   PubMed Web of Science ®Google Scholar
• Hahn JY, Cho HJ, Kang HJ, Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 2008;51:933-43
   PubMed Web of Science ®Google Scholar
• Lu G, Haider HK, Jiang S, Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation 2009;119:2587-96
   PubMed Web of Science ®Google Scholar
• Chang W, Song BW, Lim S, Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury. Stem Cells 2009;27(9):2283-92
   PubMed Web of Science ®Google Scholar
• Ray R, Novotny NM, Crisostomo PR, Sex steroids and stem cell function. Mol Med 2008;14:493-501
   PubMed Web of Science ®Google Scholar
• Yang YJ, Qian HY, Huang J, Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J 2008;29:1578-90
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Noiseux N, Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20:661-9
   PubMed Web of Science ®Google Scholar
• Mangi AA, Noiseux N, Kong D, Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-201
   PubMed Web of Science ®Google Scholar
• Li W, Ma N, Ong LL, Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007;25:2118-27
   PubMed Web of Science ®Google Scholar
• Kofidis T, de Bruin JL, Yamane T, Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 2004;22:1239-45
   PubMed Web of Science ®Google Scholar
• Song H, Kwon K, Lim S, Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol Cells 2005;19:402-7
   PubMed Web of Science ®Google Scholar
• Tang YL, Tang Y, Zhang YC, Improved graftmesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005;46:1339-50
   PubMed Web of Science ®Google Scholar
• Markel TA, Wang Y, Herrmann JL, VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol 2008;295:H2308-14
   PubMed Web of Science ®Google Scholar
• Kutschka I, Chen IY, Kofidis T, Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 2006;114:I167-73
   PubMed Web of Science ®Google Scholar
• Laflamme MA, Chen KY, Naumova AV, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-24
   PubMed Web of Science ®Google Scholar
• Copland IB, Lord-Dufour S, Cuerquis J, Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. Stem Cells 2009;27:467-77
   PubMed Web of Science ®Google Scholar
• Matter ML, Ruoslahti EA. Signaling pathway from the alpha5beta1 and alphavbeta3 integrins that elevates bcl-2 transcription. J Biol Chem 2001;276:27757-63
   PubMed Web of Science ®Google Scholar
• Akimov SS, Krylov D, Fleischman LF, Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 2000;148:825-38
   PubMed Web of Science ®Google Scholar
• Persad S, Attwell S, Gray V, Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 2001;276:27462-9
   PubMed Web of Science ®Google Scholar
• Cho HJ, Youn SW, Cheon SI, Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrinlinked kinase. Arterioscler Thromb Vasc Biol 2005;25:1154-60
   PubMed Web of Science ®Google Scholar
• White DE, Cardiff RD, Dedhar S, Mammary epithelialspecific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 2001;20:7064-72
   PubMed Web of Science ®Google Scholar
• Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995;268:233-9
   PubMed Web of Science ®Google Scholar
• Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995;11:549-99
   PubMed Web of Science ®Google Scholar
• Wehrle-Haller B, Imhof BA. The inner lives of focal adhesions. Trends Cell Biol 2002;12(8):382-9
   PubMed Web of Science ®Google Scholar
• Imhof BA, Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 2004;4:432-44
   PubMed Web of Science ®Google Scholar
• Yang J, Zhou W, Zheng W, Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 2007;107:17-29
   PubMed Web of Science ®Google Scholar
• Shujia J, Haider HK, Idris NM, Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc Res 2008;77:525-33
   PubMed Web of Science ®Google Scholar
• Cheng Z, Ou L, Zhou X, Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008;16:571-9
   PubMed Web of Science ®Google Scholar
• Zeng B, Chen H, Zhu C, Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance. Eur J Cardiothorac Surg 2008;34:850-6
   PubMed Web of Science ®Google Scholar
• Song SW, Chang W, Song BW, Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells 2009;27:1358-65
   PubMed Web of Science ®Google Scholar
• Bao C, Guo J, Lin G, TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI. Scand Cardiovasc J 2008;42:56-62
   PubMed Web of Science ®Google Scholar
• Gao F, He T, Wang H, A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol 2007;23:891-8
   PubMed Web of Science ®Google Scholar
• Matsumoto R, Omura T, Yoshiyama M, Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol 2005;25:1168-73
   PubMed Web of Science ®Google Scholar
• Guo Y, He J, Wu J, Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis. Arch Med Res 2008;39:179-88
   PubMed Web of Science ®Google Scholar
• Pasha Z, Wang Y, Sheikh R, Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 2008;77:134-42
   PubMed Web of Science ®Google Scholar
• Maurel A, Azarnoush K, Sabbah L, Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? Transplantation. 2005;80:660-5
   PubMed Web of Science ®Google Scholar
• He A, Jiang Y, Gui C, The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning. Can J Cardiol 2009;25:353-8
   PubMed Web of Science ®Google Scholar
• Shabbir A, Zisa D, Suzuki G, Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol 2009;296:H1888-97
   PubMed Web of Science ®Google Scholar
• Chen J, Baydoun AR, Xu R, Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Stem Cells 2008;26:135-45
   PubMed Web of Science ®Google Scholar
• Chen TL, Wang JA, Shi H, Cyclosporin A pre-incubation attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Scand J Clin Lab Invest 2008;68:585-93
   PubMed Web of Science ®Google Scholar